What is the VA rating for Infectious Diseases?

22 of the 25 codes in this hub share one General Rating Formula: 100 percent while active, 0 percent for the infection itself once resolved. Any residual disability is rated separately under the appropriate body system.

• Each code's own Note names non-exhaustive residual examples specific to that disease -- for example, DC 6304 (Malaria) names liver or splenic damage and central nervous system conditions; DC 6319 (Lyme disease) names arthritis, Bell's palsy, radiculopathy, ocular, or cognitive dysfunction.
• RatingScope discloses each code's own named examples but does not auto-compute a residual rating or guess which body-system hub applies -- that determination depends on the specific residual findings documented in an individual case.
• This mirrors the same open-ended residual-dispatch pattern already used for Beriberi (DC 6314) in the Nutritional Deficiencies hub.

Records to review: treatment records documenting the specific residual finding and affected body system.

4 of the 22 standard-formula codes -- DC 6301 (Visceral leishmaniasis), DC 6302 (Leprosy), DC 6312 (Nontuberculosis mycobacterium infection), and DC 6325 (Hyperinfection syndrome/disseminated strongyloidiasis) -- continue the 100 percent evaluation for a stated period after treatment ends, then require a mandatory VA examination.

• DC 6301 and DC 6302 each continue the 100 percent evaluation 6 months beyond the cessation of treatment for active disease, then require a mandatory VA examination to determine the appropriate rating.
• DC 6312 continues the 100 percent evaluation for the duration of treatment, followed by a mandatory VA examination.
• DC 6325 continues the 100 percent evaluation through active disease, followed by a mandatory VA examination.
• Any change in evaluation based on that examination (or any subsequent one) is subject to 38 CFR 3.105(e)'s procedural protections.
• RatingScope's calculator does not compute or schedule this reexamination timeline -- it discloses each code's own reexam language in the registry and here, as educational context.
• RSCH-064's own research corrected an initial assumption that only 3 codes carried this Note (DC 6301, 6311, 6312) -- DC 6311 does NOT carry it (it has its own distinct inactive-disease dispatch instead), and DC 6325 does carry it, a genuine finding made during research rather than assumed going in.

Records to review: Infectious Diseases DBQ (VA Form 21-0960I-3); treatment cessation date and mandatory VA reexamination records.

DC 6311 (Tuberculosis, miliary)'s own text reads: 'As active disease 100. Inactive disease: See §§ 4.88c and 4.89.' This hub builds only the active-disease branch.

• Sections 4.88c and 4.89 remain unresearched -- RatingScope does not guess a percentage for inactive miliary tuberculosis.
• This is the 5th confirmed instance of a recurring pattern tracked in this repository's own research standard (RSCH_STANDARD.md section 8.1): a diagnostic code whose text dispatches onward to a still-unresearched section, rather than containing its own complete criteria.
• Unlike the first four tracked instances (which all dispatch INTO section 4.88b/4.88c/4.89 from outside), this is the first instance of a code WITHIN section 4.88b itself deferring onward for its own inactive-disease rating -- confirmed by RSCH-064.
• If your records indicate the disease is inactive or resolved rather than active, this hub returns a request for more detail with an explicit citation to sections 4.88c and 4.89, rather than computing a percentage.

Records to review: treatment records documenting current disease-activity status.

DC 6311 (Tuberculosis, miliary, 38 CFR 4.88b) is confirmed structurally and topically distinct from the already-built Tuberculosis hub (38 CFR 4.97, DC 6701-6732, pulmonary tuberculosis).

• DC 6311 covers nonpulmonary, disseminated ("miliary") tuberculosis under section 4.88b's infectious-disease framework.
• The Tuberculosis hub covers pulmonary tuberculosis under section 4.97's own legacy/modern regime (DC 6701-6704/6721-6724 legacy, DC 6730-6732 modern) -- a completely different rating structure under a different CFR section.
• RSCH-064 independently re-confirmed this boundary holds; the Tuberculosis hub's own existing disclosure already states DC 6311 and DC 6312 sit outside its scope for exactly this reason.
• If a veteran's records describe pulmonary tuberculosis, the Tuberculosis hub is the applicable resource; if they describe nonpulmonary, disseminated (miliary) tuberculosis, DC 6311 in this hub applies instead.

Records to review: diagnosis records specifying pulmonary vs. nonpulmonary/disseminated tuberculosis.

DC 6310 (Syphilis, and other treponema infections) is the only code in this range with no "Evaluate under the General Rating Formula" language at all. Its entire current text is: "Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, diseases of the nervous system, vascular system, eyes, or ears (see DC 7004, DC 8013, DC 8014, DC 8015, and DC 9301)."

• There is no independent DC 6310 rating table under the current schedule -- confirmed directly against the current CFR text, matching the same pattern already established for Hiatal Hernia's DC 7346 redirect.
• This hub does not build DC 7004, DC 8013, DC 8014, DC 8015, or DC 9301 -- those are the named target codes a veteran's own records may need to be evaluated under, but they are outside this build's scope.
• Selecting Syphilis / other treponema infections as the diagnosis in this hub always returns a request for more detail, explaining this redirect and naming the target codes -- never a guessed percentage.

Records to review: diagnosis records specifying the residual finding and affected body system.

38 CFR 3.317(c)(1)-(c)(2) grants a presumption of service connection for 9 named infectious diseases for Gulf War/Southwest Asia veterans; paragraph (d) separately lists long-term health effects potentially associated with those same 9 diseases. 7 of the 9 are diagnostic codes built in this hub.

• The 9 diseases named in section 3.317(c)(2) are: Brucellosis, Campylobacter jejuni, Coxiella burnetii (Q fever), Malaria, Mycobacterium Tuberculosis, Nontyphoid Salmonella, Shigella, Visceral Leishmaniasis, and West Nile virus.
• Of these, 7 are diagnostic codes in this hub: DC 6301 (Visceral Leishmaniasis), DC 6304 (Malaria), DC 6316 (Brucellosis), DC 6330 (Campylobacter jejuni), DC 6331 (Q fever), DC 6333 (Nontyphoid Salmonella), DC 6334 (Shigella), and DC 6335 (West Nile virus). Mycobacterium Tuberculosis is separately addressed by the already-built Tuberculosis hub (38 CFR 4.97), not this one.
• This is a Part 3 service-connection-presumption provision, not a Part 4 rating-percentage rule -- it determines whether a condition is presumed connected to service, not how severely it is rated once connected.
• RatingScope discloses this pathway as evidentiary context only; it is never used as rating logic, gating, or automated computation in this hub.

Records to review: service records documenting Gulf War/Southwest Asia service dates and locations.

All 25 live diagnostic codes in 38 CFR 4.88b's DC 6300-6335 range covered by this hub, plus the confirmed-absent gap codes and structurally unrelated codes correctly excluded from it.

• DC 6300 Vibriosis (Cholera, Non-cholera) -- General Rating Formula, no mandatory reexam.
• DC 6301 Visceral leishmaniasis -- General Rating Formula, mandatory reexam 6 months post-treatment.
• DC 6302 Leprosy (Hansen's disease) -- General Rating Formula, mandatory reexam 6 months post-treatment.
• DC 6304 Malaria -- General Rating Formula, no mandatory reexam (researched separately, RSCH-061).
• DC 6305 Lymphatic filariasis, to include elephantiasis -- General Rating Formula, no mandatory reexam.
• DC 6306 Bartonellosis -- General Rating Formula, no mandatory reexam.
• DC 6307 Plague -- General Rating Formula, no mandatory reexam.
• DC 6308 Relapsing Fever -- General Rating Formula, no mandatory reexam.
• DC 6309 Rheumatic fever -- General Rating Formula, no mandatory reexam.
• DC 6310 Syphilis, and other treponema infections -- no independent percentage; pure residual redirect (DC 7004, 8013, 8014, 8015, 9301), not built here.
• DC 6311 Tuberculosis, miliary -- active-only branch built (100 percent); inactive-disease pathway (§§4.88c/4.89) is out of scope.
• DC 6312 Nontuberculosis mycobacterium infection -- General Rating Formula, mandatory reexam for the duration of treatment.
• DC 6313/6314/6315 (Avitaminosis, Beriberi, Pellagra) -- already covered by the separate Nutritional Deficiencies hub, not this one.
• DC 6316 Brucellosis -- General Rating Formula, no mandatory reexam.
• DC 6317 Rickettsial, ehrlichia, and anaplasma infections -- General Rating Formula, no mandatory reexam.
• DC 6318 Melioidosis -- General Rating Formula, no mandatory reexam.
• DC 6319 Lyme disease -- General Rating Formula, no mandatory reexam.
• DC 6320 Parasitic diseases otherwise not specified -- General Rating Formula, no mandatory reexam.
• DC 6325 Hyperinfection syndrome or disseminated strongyloidiasis -- General Rating Formula, mandatory reexam through active disease.
• DC 6326 Schistosomiasis -- own dedicated 0-percent-only branch; never reaches 100 percent for the active disease itself.
• DC 6329 Hemorrhagic fevers, including dengue, yellow fever, and others -- General Rating Formula, no mandatory reexam.
• DC 6330 Campylobacter jejuni infection -- General Rating Formula, no mandatory reexam.
• DC 6331 Coxiella burnetii infection (Q fever) -- General Rating Formula, no mandatory reexam.
• DC 6333 Nontyphoid salmonella infections -- General Rating Formula, no mandatory reexam.
• DC 6334 Shigella infections -- General Rating Formula, no mandatory reexam.
• DC 6335 West Nile virus infection -- General Rating Formula, no mandatory reexam.
• DC 6350 (Lupus), DC 6351 (HIV-related illness), and DC 6354 (Chronic Fatigue Syndrome, already its own built hub) are structurally unrelated codes elsewhere in section 4.88b/4.88a, correctly out of scope for this hub.
• Gap codes 6303, 6321, 6322, 6323, 6324, 6327, 6328, and 6332 are confirmed absent from Appendix A entirely, with no removal entry found on either source checked -- a "never assigned" finding, distinct from "removed."
• All 25 codes' current text traces to the single August 11, 2019 effective date (RIN 2900-AQ43).

Records to review: 38 CFR 4.88b full text; eCFR Appendix A amendment history.

The Infectious Diseases DBQ (VA Form 21-0960I-3) has no dedicated checkbox for any of the 9 diagnostic codes added by the August 11, 2019 rule (RIN 2900-AQ43) -- DC 6312, 6325, 6326, 6329, 6330, 6331, 6333, 6334, and 6335.

• Veterans and representatives documenting one of these 9 diagnoses on the current form must use its freetext "Other" field -- there is no purpose-built checkbox.
• This is confirmed as a real DBQ/CFR mismatch, not merely a rating-criteria conflict -- the form has simply not been updated to reflect the 2019 rule's additions.
• RatingScope discloses this gap; it does not attempt to work around it or suggest an unofficial substitute for the DBQ.

Records to review: Infectious Diseases DBQ (VA Form 21-0960I-3).

Infectious-disease evidence is strongest when different records describe the same confirmed diagnosis and active/resolved status consistently.

• Medical records can document diagnosis, diagnostic-test confirmation (e.g., culture, histopathology, serologic or PCR testing), and current disease-activity status.
• The Infectious Diseases DBQ organizes findings for many of these diagnoses, though 9 of the 25 codes in this hub have no dedicated checkbox (disclosed above).
• No single record automatically determines a percentage; the confirmed, documented active/resolved status -- and, for DC 6326, the specific acute-or-chronic finding -- matters.

Records to review: medical records; Infectious Diseases DBQ.

The public Infectious Diseases DBQ (VA Form 21-0960I-3) organizes diagnosis and disease-activity findings for many of the codes in this hub.

• The examiner gathers evidence; the examiner does not issue the final benefits decision.
• 9 of the 25 codes in this hub (all added by the 2019 rule) have no dedicated checkbox on the current form -- disclosed separately above.

Records to review: Infectious Diseases DBQ (VA Form 21-0960I-3); C&P examination; treatment history.